Mechanistically, m6A modification enhanced the expression of hepatoma-derived growth factor (HDGF), which could activate solute carrier family 2 member 4 (GLUT4) and enolase 2 (ENO2) to potentiate aerobic glycolysis in tumor cells [48]. The gene discussed is ENO2; the disease is neoplasm.